ArticleCancer research and treatment2019

The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer.

Se-Il Go et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.